v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenue:        
Grant revenue $ 736 $ 0 $ 1,094 $ 0
Total revenue $ 736 $ 0 $ 1,094 $ 0
Revenue from Contract with Customer, Product and Service [Extensible Enumeration] us-gaap:GrantMember us-gaap:GrantMember us-gaap:GrantMember us-gaap:GrantMember
Operating expenses:        
Research and development expenses $ 9,141 $ 12,939 $ 22,336 $ 24,760
General and administrative expenses 7,061 10,253 15,131 22,141
Impairment of long-lived assets 5,807 0 5,807 0
Manufacturing services 0 1,689 0 5,216
Total operating expenses 22,009 24,881 43,274 52,117
Loss from operations (21,273) (24,881) (42,180) (52,117)
Other income (expense):        
Gain on sale of VOWST Business 25,000 185 25,000 52,366
Interest income 181 546 506 1,164
Other income (expense) [1] 673 4,295 1,342 11,414
Total other income (expense), net 25,854 5,026 26,848 64,944
Net income (loss) $ 4,581 $ (19,855) $ (15,332) $ 12,827
Net income (loss) per share attributable to common stockholders - basic $ 0.47 $ (2.27) $ (1.59) $ 1.47
Net income (loss) per share attributable to common stockholders - diluted $ 0.47 $ (2.27) $ (1.59) $ 1.47
Weighted average common shares outstanding - basic 9,706,193 8,743,733 9,644,704 8,723,589
Weighted average common shares outstanding - diluted 9,747,138 8,743,733 9,644,704 8,732,176
[1] Includes $0, $0, $3,490, and $9,799 for the three and six months ended June 30, 2026 and 2025 related to reimbursement received from SPN (related party) for transition services provided by the Company.